Investors looking for a quick turnaround in the fortunes of Bayer are likely to be disappointed by chief executive Bill Anderson's assessment of the next couple of years as he delivers the group's ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results